section name header

Y-Site Injection Compatibility (1:1 Mixture)

Cefiderocol sulfate tosylate

(Mfr: SHI)(Conc: 20 mg/mLa)

I

Ciprofloxacin

(Mfr: CLA)(Conc: 2 mg/mLl)

Remarks:

Results of subvisual tests indicate increased turbidity

Ref:

3662,3670